Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective study designed to evaluate the structural and functional integrity of transcatheter or surgical bioprosthetic valves with multimodality imaging. The study further aims to confirm resolution of the early bioprosthetic valve thrombotic changes with anticoagulation.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cedars-Sinai Medical Center
• Treatments: Warfarin

Criteria

Inclusion Criteria:

• Presence of transcatheter or surgical bioprosthetic aortic valve implanted at least 48 hours prior to enrollment

• Age 18 years or older

• Ability to provide informed consent and follow-up with protocol procedures.

Exclusion Criteria:

• Renal insufficiency (creatinine > 1.5 mg/dL)

• Known allergy to iodinated contrast agents